142 results on '"Gothe, Florian"'
Search Results
2. 1½-jähriger Junge mit Ausschlag am Arm und im Gesicht
3. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
4. Human inherited complete STAT2 deficiency underlies inflammatory viral diseases
5. Successful atorvastatin treatment of pulmonary alveolar proteinosis in a child with GM‐CSF receptor deficiency
6. Single-center prospective evaluation of the first five years of cystic fibrosis newborn screening in Germany
7. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency
8. Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis
9. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
10. Novel Gain-of-Function Mutation in Stat1 Sumoylation Site Leads to CMC/CID Phenotype Responsive to Ruxolitinib
11. Single-centre prospective evaluation of the first 5 years of cystic fibrosis newborn screening in Germany.
12. Kinderlungenregister (chILD-EU) – Zusammenarbeit führt zu Fortschritten bei den seltenen und interstitiellen Lungenerkrankungen.
13. Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis
14. Schwere Komplikationen bei Lebendimpfungen
15. 14-jähriges Mädchen mit Fieber und Abgeschlagenheit nach Harnwegsinfektion
16. 1½-jähriger Junge mit Ausschlag am Arm und im Gesicht
17. Interstitial lung disease in children with aminoacyl-tRNA synthetase (ARSs) deficiencies
18. CF, PAP und EAA – oder doch ganz anders?
19. ABCA3-related interstitial lung disease beyond infancy
20. Diffuse alveolar hemorrhage in children with interstitial lung disease:Determine etiologies!
21. Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
22. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
23. STAT5B restrains human B-cell differentiation to maintain humoral immune homeostasis
24. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency
25. ABCA3-related interstitial lung disease beyond infancy.
26. Single-cell multi-omics analysis of the immune response in COVID-19
27. Diffuse alveolar hemorrhage in children with interstitial lung disease: Determine etiologies!
28. Autoimmune PAP (aPAP) in children
29. Type I interferons govern Zika virus resistance of human macrophages and microglia
30. Immune dysregulation as a consequence of genetic variants within the JAK-STAT signalling pathway
31. Zum Gesamtschuldnerausgleich bei grob fehlerhafter Medikamentengabe
32. The expansion of human T-bet high CD21 low B cells is T cell dependent
33. Monogenic susceptibility to live viral vaccines
34. Early‐onset, fatal interstitial lung disease in STAT3 gain‐of‐function patients
35. JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease
36. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
37. A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis
38. Signal transducer and activator of transcription 5B deficiency due to a novel missense mutation in the coiled-coil domain
39. Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2
40. Serum 7-Alpha-Hydroxy-4-Cholesten-3-One as a Marker for Bile Acid Loss in Children
41. Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis.
42. Human interleukin-2 receptor beta mutations associated with defects in immunity and peripheral tolerance
43. Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance
44. Human IL-2 receptor β mutations associated with defects in immunity and peripheral tolerance
45. Verkäuferpflichten und Gewährleistung beim Forderungskauf.
46. Additional file 5: Table S4. of Categorizing diffuse parenchymal lung disease in children
47. Messung von 7alpha-Hydroxy-4-cholesten-3-on als Marker von Gallensäureverlust
48. Additional file 2: Figure S1. of Categorizing diffuse parenchymal lung disease in children
49. Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis
50. Categorizing diffuse parenchymal lung disease in children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.